Stifel Financial’s Greenwich LifeSciences GLSI Stock Holding History

Stifel Financial’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	+10,023	New	+$244K	﹤0.01%	3424

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stifel Financial's GLSI Position: Q2 2026 in Review

Stifel Financial opened a new position in Greenwich LifeSciences (GLSI) in Q2 2026: 10,023 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #3424 among its holdings.

58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

Stifel Financial held 10,023 shares of Greenwich LifeSciences worth $235K as of Q2 2026.
Greenwich LifeSciences was a new Stifel Financial position in Q2 2026.
Greenwich LifeSciences made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3424 holding.
58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.